About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5429853
Allelic
Composition
Akt2tm1Hem/Akt2tm1Hem
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Akt2tm1Hem mutation (0 available); any Akt2 mutation (51 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• hyperplasia of spindle-like stromal cells
• while aged females develop ovarian cysts, young females display normal steroidogenic and reproductive function
• cysts show a severe reduction or lack of corpus luteum in aged ovaries, suggesting a cessation of estrous cycling
• ovarian cysts are characterized by thecal-interstitial hyperplasia
• 80% of females develop severe ovarian cysts; cysts increase in size with age
• ovarian cysts show increased steroidogenic capacity as indicated by an increase in the activation of steroidogenic signaling and the presence of lipids in the cells surrounding the cystic lumen
• young females treated with leutinizing hormone alone or with GnRHAnt (to induce cyst formation) show an approximate 3-fold increase in cystic area in the ovaries compared to treated wild-type mice, however hyperinsulinemia is not seen in these mutants

homeostasis/metabolism
• aged females exhibit a 2-fold increase in serum testosterone levels

reproductive system
• hyperplasia of spindle-like stromal cells
• while aged females develop ovarian cysts, young females display normal steroidogenic and reproductive function
• cysts show a severe reduction or lack of corpus luteum in aged ovaries, suggesting a cessation of estrous cycling
• ovarian cysts are characterized by thecal-interstitial hyperplasia
• 80% of females develop severe ovarian cysts; cysts increase in size with age
• ovarian cysts show increased steroidogenic capacity as indicated by an increase in the activation of steroidogenic signaling and the presence of lipids in the cells surrounding the cystic lumen
• young females treated with leutinizing hormone alone or with GnRHAnt (to induce cyst formation) show an approximate 3-fold increase in cystic area in the ovaries compared to treated wild-type mice, however hyperinsulinemia is not seen in these mutants

growth/size/body
• 80% of females develop severe ovarian cysts; cysts increase in size with age
• ovarian cysts show increased steroidogenic capacity as indicated by an increase in the activation of steroidogenic signaling and the presence of lipids in the cells surrounding the cystic lumen
• young females treated with leutinizing hormone alone or with GnRHAnt (to induce cyst formation) show an approximate 3-fold increase in cystic area in the ovaries compared to treated wild-type mice, however hyperinsulinemia is not seen in these mutants

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
polycystic ovary syndrome DOID:11612 OMIM:184700
J:185012


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/12/2024
MGI 6.23
The Jackson Laboratory